FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2588881671> ?p ?o ?g. }

• W2588881671 endingPage "100" @default.
• W2588881671 startingPage "97" @default.
• W2588881671 abstract "ABSTRACT Aim To determine the glaucoma specialists' preferences for the different brands of topical glaucoma medications available in Mexico. Materials and methods A web-based survey was sent to 150 board-certified glaucoma specialists in Mexico, with 14 questions related to brand preferences for all glaucoma medications available in Mexico. Participants were asked to select each glaucoma medication class by brand and to state the factors leading to their choice. Results Data from 111 (74%) glaucoma specialists were collected. Imot (timolol 0.5%; Sophia, Mexico) was the preferred brand for the beta-blockers (BB) class by 71% (n = 79) of the participants. Azopt (brinzolamide 1%; Alcon Lab, US) was the preferred carbonic anhydrase inhibitor (CAI) by 54% (n = 60) of the glaucoma specialists. Lumigan (bimatoprost 0.01% and 0.03%; Allergan Inc., U.S.) was the first choice for the prostaglandin analogues (PGAs) in 62% (n = 70) of the answers. The most frequently prescribed alpha-agonist (AA) was Agglad (brimonidine 0.2%; Sophia Lab, Mexico) in 44% (n = 49) of the answers. Medication accessibility (31%), cost (29%), and recommended dose (23%) were the three main factors influencing the glaucoma specialists' preferences. Conclusion Medication cost and accessibility, as well as posology, remain the main factors influencing brand preferences among glaucoma doctors. In our professional opinion, the therapeutic effect must be the leading factor when prescribing topical medications in the daily practice, so that patients receive the best treatment option. Clinical significance This survey provides an understanding of the decision-making process when prescribing glaucoma medications by glaucoma specialists in a Latin American developing country. Ideally, patient treatment should be individualized and aimed to achieve the best results possible for their specific condition. How to cite this article Lazcano-Gomez G, Alvarez-Ascencio D, Haro-Zuno C, Turati-Acosta M, Garcia-Huerta M, Jimenez-Arroyo J, Castañeda-Diez R, Castillejos-Chevez A, Gonzalez-Salinas R, Dominguez-Dueñas F, Jimenez-Roman J. Glaucoma Medication Preferences among Glaucoma Specialists in Mexico. J Curr Glaucoma Pract 2017;11(3):97-100." @default.
• W2588881671 created "2017-02-24" @default.
• W2588881671 creator A5009054443 @default.
• W2588881671 creator A5011335134 @default.
• W2588881671 creator A5041421774 @default.
• W2588881671 creator A5046453342 @default.
• W2588881671 creator A5055044922 @default.
• W2588881671 creator A5065032411 @default.
• W2588881671 creator A5069448605 @default.
• W2588881671 creator A5070197459 @default.
• W2588881671 creator A5073146258 @default.
• W2588881671 creator A5073426519 @default.
• W2588881671 creator A5083966993 @default.
• W2588881671 date "2017-01-01" @default.
• W2588881671 modified "2023-10-02" @default.
• W2588881671 title "Glaucoma Medication Preferences among Glaucoma Specialists in Mexico" @default.
• W2588881671 cites W2000248632 @default.
• W2588881671 cites W2017392248 @default.
• W2588881671 cites W2025392032 @default.
• W2588881671 cites W2028551486 @default.
• W2588881671 cites W2045334890 @default.
• W2588881671 cites W2047636647 @default.
• W2588881671 cites W2077684216 @default.
• W2588881671 cites W2096567430 @default.
• W2588881671 cites W2113888956 @default.
• W2588881671 cites W2123640761 @default.
• W2588881671 cites W2137349908 @default.
• W2588881671 cites W2147597327 @default.
• W2588881671 cites W2346037519 @default.
• W2588881671 cites W2403388797 @default.
• W2588881671 cites W2529440472 @default.
• W2588881671 cites W91481448 @default.
• W2588881671 cites W1605264106 @default.
• W2588881671 doi "https://doi.org/10.5005/jp-journals-10028-1232" @default.
• W2588881671 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/5684240" @default.
• W2588881671 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/29151684" @default.
• W2588881671 hasPublicationYear "2017" @default.
• W2588881671 type Work @default.
• W2588881671 sameAs 2588881671 @default.
• W2588881671 citedByCount "2" @default.
• W2588881671 countsByYear W25888816712021 @default.
• W2588881671 countsByYear W25888816712022 @default.
• W2588881671 crossrefType "journal-article" @default.
• W2588881671 hasAuthorship W2588881671A5009054443 @default.
• W2588881671 hasAuthorship W2588881671A5011335134 @default.
• W2588881671 hasAuthorship W2588881671A5041421774 @default.
• W2588881671 hasAuthorship W2588881671A5046453342 @default.
• W2588881671 hasAuthorship W2588881671A5055044922 @default.
• W2588881671 hasAuthorship W2588881671A5065032411 @default.
• W2588881671 hasAuthorship W2588881671A5069448605 @default.
• W2588881671 hasAuthorship W2588881671A5070197459 @default.
• W2588881671 hasAuthorship W2588881671A5073146258 @default.
• W2588881671 hasAuthorship W2588881671A5073426519 @default.
• W2588881671 hasAuthorship W2588881671A5083966993 @default.
• W2588881671 hasBestOaLocation W25888816712 @default.
• W2588881671 hasConcept C118487528 @default.
• W2588881671 hasConcept C119767625 @default.
• W2588881671 hasConcept C2776521421 @default.
• W2588881671 hasConcept C2777336333 @default.
• W2588881671 hasConcept C2778073030 @default.
• W2588881671 hasConcept C2778190193 @default.
• W2588881671 hasConcept C2778527774 @default.
• W2588881671 hasConcept C512399662 @default.
• W2588881671 hasConcept C71924100 @default.
• W2588881671 hasConceptScore W2588881671C118487528 @default.
• W2588881671 hasConceptScore W2588881671C119767625 @default.
• W2588881671 hasConceptScore W2588881671C2776521421 @default.
• W2588881671 hasConceptScore W2588881671C2777336333 @default.
• W2588881671 hasConceptScore W2588881671C2778073030 @default.
• W2588881671 hasConceptScore W2588881671C2778190193 @default.
• W2588881671 hasConceptScore W2588881671C2778527774 @default.
• W2588881671 hasConceptScore W2588881671C512399662 @default.
• W2588881671 hasConceptScore W2588881671C71924100 @default.
• W2588881671 hasIssue "3" @default.
• W2588881671 hasLocation W25888816711 @default.
• W2588881671 hasLocation W25888816712 @default.
• W2588881671 hasLocation W25888816713 @default.
• W2588881671 hasLocation W25888816714 @default.
• W2588881671 hasOpenAccess W2588881671 @default.
• W2588881671 hasPrimaryLocation W25888816711 @default.
• W2588881671 hasRelatedWork W1563049754 @default.
• W2588881671 hasRelatedWork W1965539274 @default.
• W2588881671 hasRelatedWork W1995350870 @default.
• W2588881671 hasRelatedWork W2023963282 @default.
• W2588881671 hasRelatedWork W2032524220 @default.
• W2588881671 hasRelatedWork W2039497628 @default.
• W2588881671 hasRelatedWork W2069367224 @default.
• W2588881671 hasRelatedWork W2112901860 @default.
• W2588881671 hasRelatedWork W2120821613 @default.
• W2588881671 hasRelatedWork W2180974471 @default.
• W2588881671 hasRelatedWork W2199532988 @default.
• W2588881671 hasRelatedWork W2239127809 @default.
• W2588881671 hasRelatedWork W2340564972 @default.
• W2588881671 hasRelatedWork W2885148660 @default.
• W2588881671 hasRelatedWork W3059829931 @default.
• W2588881671 hasRelatedWork W3129000201 @default.
• W2588881671 hasRelatedWork W3138570904 @default.
• W2588881671 hasRelatedWork W3171589554 @default.

• next